NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

TSX · Drug Manufacturers - Specialty & Generic · CAD

Auxly Cannabis Group Inc. (XLY.TO) Stock Analysis

Auxly Cannabis Group Inc. (XLY.TO) is a Drug Manufacturers - Specialty & Generic stock listed on TSX and quoted in Canadian Dollar.

Last Updated: October 21, 2026

XLY.TO

CA$3.36

−CA$0.02 (−0.59%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare XLY.TO with… →

XLY.TO Key Statistics

As of Oct 21, 2026
Trading
Open
CA$3.34
Previous Close
CA$3.38
Day's Range
3.34–3.44
52-Week Range
1.54–3.75
Volume
47.04K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.13
Valuation
Market Cap
CA$346.87M
P/E Ratio
14.00
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
14.58
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.10
EPS (ttm)Profit attributable to each share over the last twelve months.
0.24
Financials (FY)
Revenue (FY)
CA$151.48M+23.83%
Net Income (FY)
CA$41.86M
Profit marginThe share of revenue left as profit after all costs and taxes.
19.69%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
103.24M
1-Year Return
+2,388.89%
Dividend and dates
Earnings Date
November 12, 2026
Avg Volume
124.30K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, XLY.TO closed at CA$3.36, +2,388.89% over 1 year.

Auxly Cannabis Group Inc. (XLY.TO) has a market capitalization of CA$346.87M.

In fiscal 2025, XLY.TO reported revenue of CA$151.48M.

XLY.TO Stock Return by Calendar Year

Auxly Cannabis Group Inc. (XLY.TO) return since Jun 2018: what CA$10,000 became

1 year
CA$10,000 CA$248,889
+2,388.89%
5 years
CA$10,000 CA$140,000
+1,300.00%
Since Jun 2018
CA$10,000 CA$25,747
+157.47%

If you had invested CA$10,000 in Auxly Cannabis Group Inc. (XLY.TO) at the close on June 8, 2018, the earliest close on record here, it would have been worth CA$25,747 at the close on October 21, 2026: +157.47% in total, +11.96% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+2,217.24%
2025+262.50%
2024+300.00%
2023−50.00%
2022−89.19%
2021−27.45%
2020−52.78%
2019−40.66%
2018 (partial year)−30.27%

As of October 21, 2026.

XLY.TO Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025CA$151.48MCA$41.86M27.6%
2024CA$122.33M−CA$16.35M−13.4%
2023CA$101.08M−CA$44.51M−44.0%
2022CA$94.47M−CA$130.29M−137.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025CA$151.48MCA$86.74MCA$32.67MCA$41.86M27.6%
2024CA$122.33MCA$59.93MCA$14.71M−CA$16.35M−13.4%
2023CA$101.08MCA$21.28M−CA$25.95M−CA$44.51M−44.0%
2022CA$94.47MCA$16.51M−CA$48.98M−CA$130.29M−137.9%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

XLY.TO Valuation vs Drug Manufacturers - Specialty & Generic Median

Median of 97 stocks
MetricXLY.TODrug Manufacturers - Specialty & Generic medianvs median
P/E14.0020.3131% below
P/S ratio2.102.100% below
Profit margin19.69%−8.14%27.8 pts above

Medians across 97 Drug Manufacturers - Specialty & Generic stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Analysis

Data-derived

Company Overview

Auxly Cannabis Group Inc. (XLY.TO) is capitalised at CA$346.87M on the latest close. The company sits in the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry. The company reports 446 employees.

The most recent close on file for XLY.TO is CA$3.36, dated October 21, 2026. That is −CA$0.02 (−0.59%) against the previous close. The 52-week range on file runs from CA$1.54 to CA$3.75. The latest close sits 118.18% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of CA$151.48M. That is +23.83% against the prior fiscal year, when revenue was CA$122.33M. Net income for the same year was CA$41.86M. Profit margin runs at 19.69%. That is 27.8 percentage points above the Drug Manufacturers - Specialty & Generic median of −8.14%. Trailing earnings per share are 0.24.

Across the 4 fiscal years on file, revenue moves from CA$94.47M in 2022 to CA$151.48M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

XLY.TO trades at a trailing price-to-earnings ratio of 14. That is 31.09% below the Drug Manufacturers - Specialty & Generic median of 20.31. The forward P/E on file is 14.58. Measured against sales, the shares trade at 2.1 times revenue. On price-to-sales that is 0.23% below the Drug Manufacturers - Specialty & Generic median of 2.1. 97 Drug Manufacturers - Specialty & Generic companies report these metrics, and the medians quoted come from that group.

The trailing one-year total return is +2,388.89%. Across 5 years the annualized return works out at +69.52%. The reported beta is 1.13. Annualized volatility over the trailing 8 years is 498.28%.

Growth & Income

No dividend is on file for XLY.TO.

2026 is still running; the total return is +2,217.24% year to date. The strongest complete calendar year on file is 2024 at +300.00%; the weakest is 2022 at −89.19%. Of the 7 complete calendar years on file, 2 finished higher.

Peer Comparison

Auxly Cannabis Group Inc. (XLY.TO) operates in the Drug Manufacturers - Specialty & Generic industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Auxly Cannabis Group Inc. XLY.TO CA$346.87M 14.0
Takeda Pharmaceutical Company Limited TAK $63.67B —
Teva Pharmaceutical Industries Limited TEVA $47.37B 67.7
Haleon plc HLN $44.06B 20.5

Market caps are shown in each company's own trading currency, without conversion, and the peers are listed in order of these unconverted figures.

The Drug Manufacturers - Specialty & Generic industry average P/E ratio is 20.3x. Auxly Cannabis Group Inc. trades at a P/E of 14.0.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Drug Manufacturers - Specialty & Generic Stocks

TAK

Takeda Pharmaceutical Company Limited

$63.67B

 TEVA

Teva Pharmaceutical Industries Limited

$47.37B

 HLN

Haleon plc

$44.06B

 ZTS

Zoetis Inc.

$32.90B

 UTHR

United Therapeutics Corporation

$24.17B

 VTRS

Viatris Inc.

$21.19B
View all Drug Manufacturers - Specialty & Generic stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Auxly Cannabis Group Inc.

Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. The company offers dried and fresh cannabis, plants, seeds, and oils; and edibles, extracts, and topicals under the KOLAB PROJECT, Dosecann, BACK FORTY, Foray, and Parcel brand names. It sells its products through supply arrangements with provincial control boards and distributors, medical cannabis sales channels, and retailers, as well as to authorized wholesalers. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is headquartered in Toronto, Canada.

Visit website →